Neurology Devices Market Trends, Growth and Size Analysis By Product (Neurostimulation, Interventional Neurology, CSF Management, Neurosurgery Devices), End User (Hospitals & Clinics, Specialty Center) and Region (Americas, Europe, Asia-Pacific, Middle East & Africa) - Forecast to 2032.

Table of Contents

1. REPORT PROLOGUE

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.3. Impact of Covid-19 on the Global Neurology Devices Market

5.3.1. Impact on Supply Chain

5.3.2. Impact on Pricing

5.3.3. Impact in Major Regions (Americas, Europe, Asia-Pacific, and Middle East & Africa)

6. GLOBAL NEUROLOGY DEVICES MARKET, BY PRODUCT

6.1. Overview

6.2. Neurostimulation

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

6.2.1. Spinal cord stimulation devices

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

6.2.2. Deep brain stimulation devices

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

6.2.3. Sacral nerve stimulation

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

6.2.4. Vagus nerve stimulation

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

6.2.5. Gastric electric stimulation

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

6.3. Interventional neurology

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

6.3.1. Aneurysm coiling & embolization

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

6.3.1.1. Embolic coils

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

6.3.1.2. Flow diversion devices

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

6.3.1.3. Liquid embolic agents

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

6.3.2. Cerebral balloon angioplasty & stenting

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

6.3.2.1. Carotid artery stents

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

6.3.2.2. Filter devices

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

6.3.2.3. Balloon occlusion devices

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

6.3.3. Neurothrombectomy

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

6.3.3.1. Clot retriever

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

6.3.3.2. Suction aspiration devices

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

6.3.3.3. Snares

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

6.4. CSF management

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

6.4.1. CSF shunts

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

6.4.2. CSF drainage

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

6.5. Neurosurgery devices

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

6.5.1. Ultrasonic aspirators

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

6.5.2. Stereotactic systems

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

6.5.3. Neuroendoscopes

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

6.5.4. Aneurysm clips

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

7. GLOBAL NEUROLOGY DEVICES MARKET, BY END USER

7.1. Overview

7.2. Hospitals & Clinics

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

7.3. Specialty Center

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

7.4. Others

Market Estimates & Forecast, by Region, 2022–2030

Market Estimates & Forecast, by Country, 2022–2030

8. GLOBAL NEUROLOGY DEVICES MARKET, BY REGION

8.1. Overview

8.2. Americas

8.2.1. North America

8.2.1.1. US

8.2.1.2. Canada

8.2.2. Latin America

8.3. Europe

8.3.1. Western Europe

8.3.1.1. Germany

8.3.1.2. France

8.3.1.3. Italy

8.3.1.4. Spain

8.3.1.5. UK

8.3.1.6. Rest of Western Europe

8.3.2. Eastern Europe

8.4. Asia-Pacific

8.4.1. Japan

8.4.2. China

8.4.3. India

8.4.4. Australia

8.4.5. South Korea

8.4.6. Rest of Asia-Pacific

8.5. Middle East & Africa

8.5.1. Middle East

8.5.2. Africa

9. COMPANY LANDSCAPE

9.1. Overview

9.2. Competitive Analysis

9.3. Market Share Analysis

9.4. Major Growth Strategy in the Global Neurology Devices Market

9.5. Competitive Benchmarking

9.6. Leading Players in terms of Number of Developments in the Global Neurology Devices Market

9.7. Key developments and Growth Strategies

9.7.1. New Product Launch/Service Deployment

9.7.2. Merger & acquisitions

9.7.3. Joint Ventures

9.8. Major Players Financial Matrix & Market Ratio

9.8.1. Sales & Operating Income, 2019

9.8.2. Major Players R&D Expenditure, 2019

9.9. Major Players Capital Market Ratio

10. COMPANY PROFILES

10.1. B. Braun Melsungen AG

10.1.1. Company Overview

10.1.2. Product Overview

10.1.3. Financial Overview

10.1.4. Key Developments

10.1.5. SWOT Analysis

10.1.6. Key Strategies

10.2. Boston Scientific Corporation.

10.2.1. Company Overview

10.2.2. Product Overview

10.2.3. Financial Overview

10.2.4. Key Developments

10.2.5. SWOT Analysis

10.2.6. Key Strategies

10.3. Covidien PLC

10.3.1. Company Overview

10.3.2. Product Overview

10.3.3. Financial Overview

10.3.4. Key Developments

10.3.5. SWOT Analysis

10.3.6. Key Strategies

10.4. Integra LifeSciences Holdings Corporation

10.4.1. Company Overview

10.4.2. Product Overview

10.4.3. Financial Overview

10.4.4. Key Developments

10.4.5. SWOT Analysis

10.4.6. Key Strategies

10.5. Johnson and Johnson

10.5.1. Company Overview

10.5.2. Product Overview

10.5.3. Financial Overview

10.5.4. Key Developments

10.5.5. SWOT Analysis

10.5.6. Key Strategies

10.6. St. Jude Medical, Inc.

10.6.1. Company Overview

10.6.2. Product Overview

10.6.3. Financial Overview

10.6.4. Key Developments

10.6.5. SWOT Analysis

10.6.6. Key Strategies

10.7. Stryker Corporation

10.7.1. Company Overview

10.7.2. Product Overview

10.7.3. Financial Overview

10.7.4. Key Developments

10.7.5. SWOT Analysis

10.7.6. Key Strategies

10.8. W.L. Gore & Associates, Inc.

10.8.1. Company Overview

10.8.2. Product Overview

10.8.3. Financial Overview

10.9. Key Developments

10.9.1. SWOT Analysis

10.9.2. Key Strategies

10.10. Esaote

10.10.1. Company Overview

10.10.2. Product Overview

10.10.3. Financial Overview

10.10.4. Key Developments

10.10.5. SWOT Analysis

10.10.6. Key Strategies

10.11. Others

11. APPENDIX

11.1. References

11.2. Related Reports

NOTE:

This table of content is tentative and subject to change as the research progresses.

• In section 10, major 10 companies will be profiled. Each company will be profiled based on the Market Overview, Financials, and Product Portfolio, Business Strategies, and Recent Development parameters.

• Please note: The financial details of the company cannot be provided if the information is not available in the public domain and or from reliable sources. 

LIST OF TABLES

TABLE 1 GLOBAL NEUROLOGY DEVICES MARKET SYNOPSIS, 2022–2030

TABLE 2 GLOBAL NEUROLOGY DEVICES MARKET ESTIMATES & FORECAST, 2022–2030 (USD MILLION)

TABLE 3 GLOBAL NEUROLOGY DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 4 GLOBAL NEUROLOGY DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 5 GLOBAL NEUROLOGY DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)

TABLE 6 NORTH AMERICA: NEUROLOGY DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 7 NORTH AMERICA: NEUROLOGY DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 8 US: NEUROLOGY DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 9 US: NEUROLOGY DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 10 CANADA: NEUROLOGY DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 11 CANADA: NEUROLOGY DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 12 LATIN AMERICA: NEUROLOGY DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 13 LATIN AMERICA: NEUROLOGY DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 14 EUROPE: NEUROLOGY DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 15 EUROPE: NEUROLOGY DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 16 WESTERN EUROPE: NEUROLOGY DEVICES MARKET, BY PORTABILITY, 2022–2030 (USD MILLION)

TABLE 17 WESTERN EUROPE: NEUROLOGY DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 18 EASTERN EUROPE: NEUROLOGY DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 19 EASTERN EUROPE: NEUROLOGY DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 20 ASIA-PACIFIC: NEUROLOGY DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 21 ASIA-PACIFIC: NEUROLOGY DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION)

TABLE 22 MIDDLE EAST & AFRICA: NEUROLOGY DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)

TABLE 23 MIDDLE EAST & AFRICA: NEUROLOGY DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL NEUROLOGY DEVICES MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL NEUROLOGY DEVICES MARKET

FIGURE 4 GLOBAL NEUROLOGY DEVICES MARKET SHARE, BY PRODUCT, 2019 (%)

FIGURE 5 GLOBAL NEUROLOGY DEVICES MARKET SHARE, BY END USER, 2019 (%)

FIGURE 6 GLOBAL NEUROLOGY DEVICES MARKET SHARE, BY REGION, 2019 (%)

FIGURE 7 AMERICAS: NEUROLOGY DEVICES MARKET SHARE BY REGION, 2019 (%)

FIGURE 7 NORTH AMERICA: NEUROLOGY DEVICES MARKET SHARE, BY COUNTRY, 2019 (%)

FIGURE 8 EUROPE: NEUROLOGY DEVICES MARKET SHARE, BY REGION, 2019 (%)

FIGURE 9 WESTERN EUROPE: NEUROLOGY DEVICES MARKET SHARE, BY COUNTRY, 2019 (%)

FIGURE 10 ASIA-PACIFIC: NEUROLOGY DEVICES MARKET SHARE, BY COUNTRY, 2019 (%)

FIGURE 11 MIDDLE EAST & AFRICA: NEUROLOGY DEVICES MARKET SHARE, BY COUNTRY, 2019 (%)

FIGURE 12 GLOBAL NEUROLOGY DEVICES MARKET: COMPANY SHARE ANALYSIS, 2019 (%)

FIGURE 13 BRAUN MELSUNGEN AG.: KEY FINANCIALS

FIGURE 14 BRAUN MELSUNGEN AG: SEGMENTAL REVENUE

FIGURE 15 BRAUN MELSUNGEN AG: REGIONAL REVENUE

FIGURE 16 BOSTON SCIENTIFIC CORPORATION.: KEY FINANCIALS

FIGURE 17 BOSTON SCIENTIFIC CORPORATION SEGMENTAL REVENUE

FIGURE 18 BOSTON SCIENTIFIC CORPORATION.: REGIONAL REVENUE

FIGURE 19 INTEGRA LIFESCIENCES HOLDINGS CORPORATION

FIGURE 20 JOHNSON AND JOHNSON

FIGURE 21 MEDTRONIC INC.

FIGURE 22 ST. JUDE MEDICAL, INC

FIGURE 23 STRYKER CORPORATION

FIGURE 24 W.L. GORE & ASSOCIATES, INC.

FIGURE 25 MAGSTIM CO LTD.